Speed
43 days to first decision for all manuscripts
45 days to first decision for reviewed manuscripts only
94 days from submission to acceptance
10 days from acceptance to publication
Citation Impact
1.134 - Source Normalized Impact per Paper (SNIP)
0.601 - SCImago Journal Rank (SJR)
2.9 - CiteScore
Usage
288,136 Downloads (2021)
59 Altmetric mentions
Articles
Page 5 of 7
-
Citation: Thyroid Research 2013 6(Suppl 2):A66
-
The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
Citation: Thyroid Research 2013 6(Suppl 2):A64 -
Recurrence of optic nerve neuropathy - a possible side effect of intravenous methylprednisolone pulses treatment
Citation: Thyroid Research 2013 6(Suppl 2):A62 -
Hashimoto’s disease - from theory to practice
Citation: Thyroid Research 2013 6(Suppl 2):A60 -
Evaluation of ultrasound-guided fine needle aspiration biopsy (USG-FNAB) of thyroid nodules: 12 years of accepted diagnostic algorithm in Holycross Cancer Centre (HCC) in Kielce
Citation: Thyroid Research 2013 6(Suppl 2):A58 -
Curiosa in fine needle aspiration biopsy of the thyroid gland
Citation: Thyroid Research 2013 6(Suppl 2):A56 -
Clinical experience in the management of patients with Graves' orbitopathy treated according to the novel protocol of glucocorticoid therapy designed in the Department of Endocrinology, Metabolism and Internal Medicine of Poznan University of Medical Sciences
Citation: Thyroid Research 2013 6(Suppl 2):A54 -
Maintenance of iodine intake
Citation: Thyroid Research 2013 6(Suppl 2):A52 -
Imaging techniques in diagnostics, differentiation and monitoring of different types of thyroiditis
Citation: Thyroid Research 2013 6(Suppl 2):A50 -
Molecular mechanism of thyroid hormone action in carcinogenesis
Citation: Thyroid Research 2013 6(Suppl 2):A48 -
Aberrant expression of follicle stimulating hormone receptors (FSHR) in thyroid neoplasia
Citation: Thyroid Research 2013 6(Suppl 2):A46 -
Subclinical hypothyroidism in population of aging Polish women and men over 65yrs old and cardiovascular risk factor, endogenous vitamin D levels and its gene receptor polymorphisms – PolSenior Study
Citation: Thyroid Research 2013 6(Suppl 2):A44 -
Etiopathogenesis of Graves-Basedow disease; where we are and where we are going
Citation: Thyroid Research 2013 6(Suppl 2):A43 -
The correct interpretation of thyroid FNAB cytological result by the endocrinologist as a basis for further optimal diagnostics and treatment
Citation: Thyroid Research 2013 6(Suppl 2):A38 -
The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
Citation: Thyroid Research 2013 6(Suppl 2):A33 -
Metastasis to the thyroid gland as the first clinical manifestation of lung cancer – case report
Citation: Thyroid Research 2013 6(Suppl 2):A31 -
Picture of thyroid cancer in 2012
Citation: Thyroid Research 2013 6(Suppl 2):A29 -
Effect of triiodothyronine on hyperandrogenism in women
Citation: Thyroid Research 2013 6(Suppl 2):A27 -
The ATA guidelines of thyrotoxicosis
Citation: Thyroid Research 2013 6(Suppl 2):A25 -
Amiodarone and the thyroid dysfunction
Citation: Thyroid Research 2013 6(Suppl 2):A23 -
How far are we from understanding the genetic basis of Hashimoto’s thyroiditis?
Citation: Thyroid Research 2013 6(Suppl 2):A21 -
The propeptide of human thyroid peroxidase is not required for its cellular, enzymatic or immunological activity
Citation: Thyroid Research 2013 6(Suppl 2):A19 -
Diagnostic performance evaluation of post-operative serum calcitonin (CT) levels as a factor for good prognosis in medullary thyroid carcinoma (MTC)
Citation: Thyroid Research 2013 6(Suppl 2):A17 -
Recent progress in thyroid surgery
Citation: Thyroid Research 2013 6(Suppl 2):A15 -
The proteins of iodine metabolism in the pathophysiology of the thyroid gland
Citation: Thyroid Research 2013 6(Suppl 2):A13 -
Expression mRNA pattern of retinoic acid and retinoid X nuclear receptor subtypes in thyroid carcinomas
Citation: Thyroid Research 2013 6(Suppl 2):A11 -
Thyroid hormones – obesity and metabolic syndrome
Citation: Thyroid Research 2013 6(Suppl 2):A5 -
Metabolomics provides new information on the changes occurring in thyroid tumours
Citation: Thyroid Research 2013 6(Suppl 2):A3 -
The risk of malignancy of the thyroid nodule/focal lesion – an assessment by ultrasound, based on our own scoring system
Citation: Thyroid Research 2013 6(Suppl 2):A1 -
Thyroid heterogeneity, as indicated by the CV of ultrasonographic intensities, correlates with anti-thyroid peroxidase antibodies in euthyroid Hashimoto’s thyroiditis
To prospectively evaluate the heterogeneous appearance of the thyroid gland, reflecting inflammation and destruction in euthyroid Hashimoto’s thyroiditis (HT), we investigated the clinical utilities of the het...
Citation: Thyroid Research 2013 6:5 -
Iodine-131 induced hepatotoxicity in previously healthy patients with Grave’s disease
To describe the association of the rare and serious complication of liver toxicity in previously healthy Grave’s disease (GD) patients after the treatment with radioactive iodine 131I (RAI).
Citation: Thyroid Research 2013 6:4 -
Results and summary of voting among the audience during presentation and discussion of Medullary Thyroid Carcinoma clinical guidelines prepared by American Thyroid Association
The one-day ETA-CRN meeting, preceding the ETA meeting in Lisbon, was planned in advance to provide a thorough assessment of the European response to the published American Thyroid Association MTC guidelines. ...
Citation: Thyroid Research 2013 6(Suppl 1):S12 -
Presentation of points of general discussion and voting among the speakers of the European Thyroid Association-Cancer Research Network (ETA-CRN) meeting in Lisbon, 2009, entitled ”European comments to ATA medullary thyroid cancer guidelines”
The main subjects of discussion, held online within the ETA-CRN board invited 16 expert-panelists are shown. The ad hoc emerged ETA-CRN panel of experts (EPE) first congratulated Professor Kloos and the ATA Ta...
Citation: Thyroid Research 2013 6(Suppl 1):S11 -
Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe
Hyperparathyroidism occurs in 20-30% of MEN2A syndrome patients. It is usually associated with mild disease and is frequently asymptomatic, especially in younger age. There is genotype/phenotype association an...
Citation: Thyroid Research 2013 6(Suppl 1):S10 -
Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers – the role of Ct serum level
Authors summarize in this brief review results of European discussion, held on ETA-CRN Meeting in Lisbon, 2009, on the American Thyroid Association Medullary Thyroid Cancer (MTC) Guidelines published in the sa...
Citation: Thyroid Research 2013 6(Suppl 1):S9 -
The optimal range of RET mutations to be tested: European comments to the guidelines of the American Thyroid Association
In the 9th ETA-CRN Meeting (September 2009, Lisbon) some recommendations from the American Thyroid Association (ATA) guidelines for the management of medullary thyroid cancer (MTC) were discussed by an European P...
Citation: Thyroid Research 2013 6(Suppl 1):S8 -
Treatment of advanced medullary thyroid cancer
Therapy decisions in advanced medullary thyroid carcinoma should be guided by a critical appraisal of the natural disease course (slowly progressive vs. aggressive) and benefits and side effects of therapy. Th...
Citation: Thyroid Research 2013 6(Suppl 1):S7 -
Clinical comments related to medullary thyroid cancer diagnosis and management
The American Thyroid Association (ATA) and more recently the European Thyroid Association (ETA) Guidelines on diagnosis and treatment of medullary thyroid carcinoma (MTC) have provided an excellent tool which ...
Citation: Thyroid Research 2013 6(Suppl 1):S6 -
Postoperative follow up in patients showing no evident residual disease - cut-offs for imaging/ intervention
The European Group generally agrees with the American guidelines on the issue of the indications for additional surgery in patients with recurrence of medullary thyroid cancer. The discussions have been focuse...
Citation: Thyroid Research 2013 6(Suppl 1):S5 -
Serum calcitonin estimation in medullary thyroid cancer: basal or stimulated levels?
Calcitonin (Ct) is a tumour marker essential for the diagnosis and follow-up of medullary thyroid cancer (MTC). Accurate and consistent measurements of serum Ct are of critical importance. Ct measurements by d...
Citation: Thyroid Research 2013 6(Suppl 1):S4 -
Extent of surgery in clinically evident but operable MTC – when is central and/or lateral lympadenectomy indicated?
Medullary thyroid carcinoma (MTC) metastasizes very early lymphogeneously. It has been shown that the presence of lymph node metastases is associated with a worse outcome. Postoperative biochemical cure, i.e. ...
Citation: Thyroid Research 2013 6(Suppl 1):S3 -
Calcitonin estimation in patients with nodular goiter and its significance for early detection of MTC: european comments to the guidelines of the American Thyroid Association
One of the most discussed and controversial issue in the management of thyroid nodules is the need to perform a routine measurement of serum Calcitonin (Ct) in all cases. The American Thyroid Association guide...
Citation: Thyroid Research 2013 6(Suppl 1):S2 -
Introduction to European comments on “Medullary Thyroid Cancer: management guidelines of the American Thyroid Association”
Guest Editors of Thyroid Research supplement devoted to medullary thyroid cancer present the history on how the discussion about “Medullary Thyroid Cancer: management guidelines of the American Thyroid Associatio...
Citation: Thyroid Research 2013 6(Suppl 1):S1 -
Spectrum of lithium induced thyroid abnormalities: a current perspective
Lithium is an integral drug used in the management of acute mania, unipolar and bipolar depression and prophylaxis of bipolar disorders. Thyroid abnormalities associated with treatment with lithium have been w...
Citation: Thyroid Research 2013 6:3 -
Managing thyroid dysfunction in selected special situations
Managing thyroid dysfunction is simple at first glance, the idea is to bring hormone levels in the euthyroid range, treat with antithyroid drugs, radio-iodine or surgery if toxic and replace with thyroxine or ...
Citation: Thyroid Research 2013 6:2 -
Case report: rare case of infiltration of small lymphocytic B-cell lymphoma in the thyroid gland of female patient with B-cell chronic lymphocytic leukemia (CLL-B/SLL-B)
The article presents a case of 57-year-old woman with the infiltration of rare small lymphocytic B cell lymphoma in the thyroid gland. Initially, the patient was followed-up due to chronic lymphocytic B-cell l...
Citation: Thyroid Research 2013 6:1 -
Role of metallothioneins in benign and malignant thyroid lesions
Recent findings in the past two decades have brought many insights into the biology of thyroid benign and malignant lesions, in particular the papillary and follicular thyroid cancers. Although, much progress ...
Citation: Thyroid Research 2012 5:26 -
Oxidative damage to macromolecules in the thyroid - experimental evidence
Whereas oxidative reactions occur in all tissues and organs, the thyroid gland constitutes such an organ, in which oxidative processes are indispensable for thyroid hormone synthesis. It is estimated that huge...
Citation: Thyroid Research 2012 5:25 -
High level of oxidized nucleosides in thyroid mitochondrial DNA; damaging effects of Fenton reaction substrates
The mitochondrial DNA (mtDNA) lies in close proximity to the free radical-producing electron transport chain, thus, it is highly prone to oxidative damage. Oxyphilic type of follicular thyroid carcinoma consis...
Citation: Thyroid Research 2012 5:24 -
Evaluation of efficacy of iodine prophylaxis in Poland based on the examination of schoolchildren living in Opoczno Town (Lodz Voivodship)
In 1997 a currently obligatory model of iodine prophylaxis, based on mandatory iodization of household salt with 30 mg KI/kg, was introduced. The aim of our study was to assess the iodine intake among school-a...
Citation: Thyroid Research 2012 5:23